FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
Margolis Jeff Eliot |
2. Issuer Name
and
Ticker or Trading Symbol
RespireRx Pharmaceuticals Inc. [ RSPI ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) VP, Treasurer & Secretary |
C/O RESPIRERX PHARMACEUTCALS INC., 126 VALLEY ROAD, SUITE C |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
GLEN ROCK, NJ 07452 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 9/14/2015 | X | 507374 | A | (1) | 15618816 | D | |||
Common Stock | 9/14/2015 | S (1) | 483872 | D | (1) | 15134944 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Warrants (right to buy) | $0.021 | 8/28/2015 | J (2) | 325022 | (2) | 9/30/2020 | Common Stock | 325022 | $0 | 325022 | D (4) | ||||
Warrants (right to buy) | $0.035 | 9/14/2015 | X | 507374 | (1) | 9/15/2015 | Common Stock | 507374 | (1) | 0 | D | ||||
Warrants (right to buy) | $0.021 | 9/28/2015 | J (2) | 309975 | (2) | 9/30/2020 | Common Stock | 309975 | $0 | 634997 | D (4) | ||||
Warrants (right to buy) | $0.021 | 11/2/2015 | J (2) | 939729 | (2) | 9/30/2020 | Common Stock | 939729 | $0 | 1574726 | D (4) | ||||
Common Stock Options (to purchase shares of Common Stock) | $0.0227 | 3/31/2016 | A | 24000000 | (3) | 3/31/2021 | Common Stock | 24000000 | $0 | 24000000 | D (4) | ||||
Common Stock Options (to purchase shares of Common Stock) | $0.0197 | (5) | 8/18/2022 | Common Stock | 10000000 | 10000000 | D (4) | ||||||||
Common Stock Options (to purchase shares of Common Stock) | $0.025 | (6) | 6/30/2022 | Common Stock | 15000000 | 15000000 | D (4) | ||||||||
Common Stock Options (to purchase shares of Common Stock) | $0.05 | (7) | 7/17/2019 | Common Stock | 5000000 | 5000000 | D (8) |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Margolis Jeff Eliot
C/O RESPIRERX PHARMACEUTCALS INC. 126 VALLEY ROAD, SUITE C GLEN ROCK, NJ 07452 |
X |
|
VP, Treasurer & Secretary |
|
Signatures
|
||
/s/ Jeff Eliot Margolis | 4/4/2016 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |